Adenovirus-Derived Nano-Capsid Platforms for Targeted Delivery and Penetration of Macromolecules into Resistant and Metastatic Tumors

By sjmartinez • June 28, 2023

Benhaghnazar RL, Medina-Kauwe L. Adenovirus-Derived Nano-Capsid Platforms for Targeted Delivery and Penetration of Macromolecules into Resistant and Metastatic Tumors. Cancers (Basel). 2023 Jun 19;15(12):3240. doi: 10.3390/cancers15123240. PMID: 37370850.

Tags: adenovirus penton base, biological therapeutics, General Internal Medicine, HER3, macromolecular delivery, macromolecule, metastatic, penton base, Publications, resistant, tumor targeting

Oliceridine: Examining the clinical evidence, pharmacology, and contested mechanism of action of the first FDA-approved biased opioid agonist

Prommer EE. Oliceridine: Examining the clinical evidence, pharmacology, and contested mechanism of action of the first FDA-approved biased opioid agonist. J Opioid Manag. 2025 Sep-Oct;21(5):377-387.[...]

Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trials

Gresham G, Henry NL, Bandos H, Calsavara VF, Cecchini RS, Diniz MA, Hays RD, Luu M, Kim S, Rogatko A, Yothers G, Ganz PA, Tighiouart[...]

Cardiovascular Multimorbidity in Older Adults in the United States by Race and Sex

Green MD, Mentz RJ, Greene SJ, Hammill BG, Essien UR, Xian Y, Michos ED, Thorpe RJ Jr, Dupre ME, Mac Grory B, Chiu CT, O'Brien[...]